✍ Scribed by David M. Goldenberg
No coin nor oath required. For personal study only.
This supplement includes 16 representative articles presented at the 12^th^ Conference on Cancer Therapy With Antibodies and Immunconjugates, Parsippany, New Jersey, October 16‐18, 2008, encompassing cancer treatment with unconjugated and isotope‐conjugated antibodies targeting selective cancer biomarkers. Cancer 2010;116(4 suppl):1011–2. © 2010 American Cancer Society.
📜 SIMILAR VOLUMES
body fragments and peptides is a problem in the therapeutic application of such agents. However, cationic amino acids have been shown to reduce renal accretion.
We determined whether transduction of the monocyte chemoattractant protein-1 (MCP-1) gene into MDR human lung cancer cells affected their tumorigenicity and sensitivity to antibody-dependent cellular cytotoxicity (ADCC) reaction mediated by the anti-P-glycoprotein (P-gp) monoclonal antibody MRK16. T